The molecular genetics of chronic neutrophilic leukaemia: Defining a new era in diagnosis and therapy

Current Opinion in Hematology

Volumn 21, Issue 2, 2014, Pages 148-154

  Elliott, Michelle A ^a,b   Tefferi, Ayalew ^a  

^a Division of Hematology/Oncology   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Chronic; Colony stimulating factor 3 receptor gene mutations; CSF3RT618I; Leukaemia; Neutrophilic

Indexed keywords

CHROMOSOMES; DISEASE PROGRESSION; HUMANS; LEUKEMIA, NEUTROPHILIC, CHRONIC; MUTATION;

EID: 84894042757     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000014     Document Type: Review

References (62)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumours: pathology and genetics of tumours and lymphoid tissue. Lyon, France: IARC Press; 2001.
2. Bain BJ, Vardiman J, Thiele J. WHO classification of tumours of haematopoietic and lymphoid tissue: chronic neutrophilic leukaemia. Swerdlow S, Campo E, Harris NL, editors. Geneva, Switzerland: WHO; 2008. pp. 38-39.
3. Elliott M.A DG, Tefferi A, Hanson CA. Chronic neutrophilic leukemia (CNL): a long-term clinical, pathologic, and cytogenetic study. Leukemia 2001; 94:35-41.
4. Standen GR, Steers FJ, Jones L. Clonality of chronic neutrophilic leukaemia associated with myeloma: analysis using the X-linked probe M27 beta. J Clin Pathol 1993; 46:297-298.
5. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114:937-951.
6. Elliott MA, Hanson CA, Dewald GW, et al. WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature. Leukemia 2005; 19:313-317.
7. Ortiz-Cruz K, Glenda A-J, Salvatore JR. Chronic neutrophilic leukemia with JAK2 gene mutation. Commun Oncol 2012; 9:127-131.
8. Saxson JE, Gotlib J, Pollyea DA, et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med 2013; 368:1781-1790.
9. Sardanani A, Lasho TL, Laborde RR, et al. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia 2013; 27:1870-1873.
10. Tuohy E. A case of splenomegaly with polymorphonuclear neutrophil hyperleukocytosis. Am J Med Sci 1920; 160:18-25.
11. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100:2292-2302.
12. Bohm J, Schaefer HE. Chronic neutrophilic leukaemia: 14 new cases of an uncommon myeloproliferative disease. J Clin Pathol 2002; 55:862-864.
13. Storek J. Chronic neutrophilic leukemia: case report documenting the absence of bcr-abl rearrangement. Am J Hematol 1992; 41:304.
14. Ohtsuki T, Katsura Y, Mizukami H, et al. Elevated neutrophil function in chronic neutrophilic leukemia. Am J Hematol 1992; 41:50-56.
15. Kwong YL, Cheng G. Clonal nature of chronic neutrophilic leukemia [comment]. Blood 1993; 82:1035-1036.
16. Meyer S, Feremans W, Cantiniaux B, et al. Successful alpha-2b-interferon therapy for chronic neutrophilic leukemia. Am J Hematol 1993; 43:307-309.
17. Hasle H, Olesen G, Kerndrup G, et al. Chronic neutrophil leukaemia in adolescence and young adulthood. Br J Haematol 1996; 94:628-630.
18. Matano S, Nakamura S, Kobayashi K, et al. Deletion of the long arm of chromosome 20 in a patient with chronic neutrophilic leukemia: cytogenetic findings in chronic neutrophilic leukemia. Am J Hematol 1997; 54:72-75.
19. Yanagisawa K, Ohminami H, Sato M, et al. Neoplastic involvement of granulocytic lineage, not granulocytic-monocytic, monocytic, or erythrocytic lineage, in a patient with chronic neutrophilic leukemia. Am J Hematol 1998; 57:221-224.
20. Terre C, Garcia I, Bastie JN, et al. A case of chronic neutrophilic leukemia with deletion (11)(q23). Cancer Genet Cytogenet 1999; 110:70-71.
21. Kojima K, Yasukawa M, Hara M, et al. Familial occurrence of chronic neutrophilic leukaemia. Br J Haematol 1999; 105:428-430.
22. Frank MB, Norwood TH, Willerford DM. Chimeric del20q in a case of chronic neutrophilic leukemia. Am J Hematol 2000; 64:229-231.
23. Willard RJ, Turiansky GW, Genest GP, et al. Leukemia cutis in a patient with chronic neutrophilic leukemia. J Am Acad Dermatol 2001; 44 (2 Suppl):365-369.
24. Piliotis E, Kutas G, Lipton JH. Allogeneic bone marrow transplantation in the management of chronic neutrophilic leukemia. Leuk Lymphoma 2002; 43:2051-2054.
25. Kobayashi S, Yamashita K, Takeoka T, et al. Calpain-mediated X-linked inhibitor of apoptosis degradation in neutrophil apoptosis and its impairment in chronic neutrophilic leukemia. J Biol Chem 2002; 277:33968-33977.
26. Bohm J, Kock S, Schaefer HE, Fisch P. Evidence of clonality in chronic neutrophilic leukaemia. J Clin Pathol 2003; 56:292-295.
27. Bench AJ, Nacheva EP, Champion KM, Green AR. Molecular genetics and cytogenetics of myeloproliferative disorders. Baillieres Clin Haematol 1998; 11:819-848.
28. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89:2079-2088.
29. Jatiani SS, Baker SJ, Silverman LR, Reddy EP. Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies. Genes Cancer 2010; 1:979-993.
30. Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352:1779-1790.
31. Jones AV, Kreil S, Zoi K, et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005; 106:2162-2168.
32. Levine RL, Loriaux M, Huntly BJ, et al. The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia. Blood 2005; 106:3377-3379.
33. Steensma DP, Dewald GW, Lasho TL, et al. The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both 'atypical' myeloproliferative disorders and myelodysplastic syndromes. Blood 2005; 106:1207-1209.
34. Mc Lornan DP, Percy MJ, Jones AV, et al. Chronic neutrophilic leukemia with an associated V617F JAK2 tyrosine kinase mutation. Haematologica 2005; 90:1696-1697.
35. Lea NC, Lim Z, Westwood NB, et al. Presence of JAK2 V617F tyrosine kinase mutation as a myeloid-lineage-specific mutation in chronic neutrophilic leukaemia. Leukemia 2006; 20:1324-1326.
36. Kako S, Kanda Y, Sato T, et al. Early relapse of JAK2 V617F-positive chronic neutrophilic leukemia with central nervous system infiltration after unrelated bone marrow transplantation. Am J Hematol 2007; 82:386-390.
37. Thiele J. Philadelphia chromosome-negative chronic myeloproliferative disease. Am J Clin Pathol 2009; 132:261-280.
38. Sugino K, Gocho K, Ota H, et al. Miliary tuberculosis associated with chronic neutrophilic leukemia. Int Med 2009; 48:1283-1287.
39. Gajendra S, Gupta R, Chandgothia M, et al. Chronic neutrophilic leukemia with V617F JAK2 mutation. Indian J Hematol Blood Transfusion 2012. [Epub ahead of print]
40. Lee J-H, Ha JS, Ryoo NH, et al. A case of acute myeloid leukemia transformed from JAK2 V617F-positive chronic neutrophilic leukemia. Lab Med Online 2012; 2:101-104.
41. Nedeljkovic N, He S, Szer J, Juneja S. Chronic neutrophilia associated with myeloma: is it clonal? Leuk Lymphoma 2013. [Epub ahead of print]
42. Zhang X, Pan J, Guo J. Presence of the JAK2 V617F mutation in a patient with chronic neutrophilic leukemia and effective response to interferon alfa-2b. Acta Haematol 2013; 130:44-46.
43. Beekman R, Touw IP. G-CSF and its receptor in myeloid malignancy. Blood 2010; 115:5131-5136.
44. Dong F, van Buitenen C, Pouwels K, et al. Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol Cell Biol 1993; 13:7774-7781.
45. Ito T, Kojima H, Otani K, et al. Chronic neutrophilic leukemia associated with monoclonal gammopathy of undetermined significance. Acta Haematol 1996; 95:140-143.
46. Rovira M, Cervantes F, Nomdedeu B, Rozman C. Chronic neutrophilic leukaemia preceding for seven years the development of multiple myeloma. Acta Haematol 1990; 83:94-95.
47. Standen GR, Jasani B, Wagstaff M, Wardrop CA. Chronic neutrophilic leukemia and multiple myeloma. An association with lambda light chain expression. Cancer 1990; 66:162-166.
48. Kohmura K, Miyakawa Y, Kameyama K, et al. Granulocyte colony stimulating factor-producing multiple myeloma associated with neutrophilia. Leuk Lymphoma 2004; 45:1475-1479.
49. Kusaba N, Yoshida H, Ohkubo F, et al. [Granulocyte-colony stimulating factorproducing myeloma with clinical manifestations mimicking chronic neutrophilic leukemia]. [Rinsho ketsueki] Jpn J Clin Hematol 2004; 45:228-232.
50. Dong F, Brynes RK, Tidow N, et al. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med 1995; 333:487-493.
51. Germeshausen M, Ballmaier M, Welte K. Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey. Blood 2007; 109:93-99.
52. Beekman R, Valkhof MG, Sanders MA, et al. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood 2012; 119:5071-5077.
53. Beekman R, Valkhof M, van Strien P, et al. Prevalence of a new auto-activating colony stimulating factor 3 receptor mutation (CSF3R-T595I) in acute myeloid leukemia and severe congenital neutropenia. Haematologica 2013; 98:e62-e63.
54. Plo I, Zhang Y, Le Couedic JP, et al. An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia. J Exp Med 2009; 206:1701-1707.
55. Forbes LV, Gale RE, Pizzey A, et al. An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia. Oncogene 2002; 21:5981-5989.
56. Piazza R, Valletta S, Winkelmann N, et al. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat Genet 2013; 45:18-24.
57. Meggendorfer M, Bacher U, Alpermann T, et al. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Leukemia 2013; 27:1852-1860.
58. Damm F, Itzykson R, Kosmider O, et al. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias. Leukemia 2013; 27:1401-1403.
59. Laborde RR, Patnaik MM, Lasho TL, et al. SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML. Leukemia 2013; 27:2100-2102.
60. Thol F, Suchanek KJ, Koenecke C, et al. SETBP1 mutation analysis in 944 patients with MDS and AML. Leukemia 2013; 27:2072-2075.
61. Makishima H, Yoshida K, Nguyen N, et al. Somatic SETBP1 mutations in myeloid malignancies. Nat Genet 2013; 45:942-946.
62. Goto H, Hara T, Tsurumi H, et al. Chronic neutrophilic leukemia with congenital Robertsonian translocation successfully treated with allogeneic bone marrow transplantation in a young man. Int Med 2009; 48:563-567.